{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:44:26Z","timestamp":1790671466725,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With the development of whole-genome sequencing technology, non-invasive prenatal testing (NIPT) has been applied gradually to screen chromosomal microdeletions and microduplications that cannot be detected by traditional karyotyping. However, in NIPT, some false positives and false negatives occur. This study aimed to investigate the applicability of extended NIPT (NIPT-PLUS) in the detection of chromosomal aneuploidy and microdeletion\/microduplication syndrome (MMS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 452 pregnancies that underwent prenatal diagnostic testing (amniocentesis or chorionic villus sampling) by chromosomal microarray analysis (CMA), were screened by NIPT-PLUS from the peripheral blood sample of the pregnant women. The results of the two tested items were compared and analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 452 cases, 335 (74.12%) had positive CMA results, and 117 (25.88%) had no abnormal results. A total of 86 cases of trisomy 21, 18 and 13 and sex chromosome aneuploidy (SCA) were detected by CMA and NIPT-PLUS, with a detection rate of 96.51% (83\/86). Among them, the detection rates of T18, T13; 47, XXY; 47, XXX and 47 XYY were 100%, and the detection rates of T21 and 45 XO were 96.55% and 90%, respectively. The detection sensitivity of rare chromosomal trisomy (RAT) was 80% (4\/5). The positive predictive values of NIPT-PLUS for chromosome aneuploidy T21, T18 and T13 and for SCA and RAT were 90.32%, 87.50%, 25.00%, 88.89% and 50%, respectively. A total of 249 cases (74.32%) of chromosomal MMS were detected by CMA. The detection rate of NIPT-PLUS was 63.86% (159\/249), and 90 cases (36.14%) were missed. The larger the MMS fragment, the higher the NIPT-PLUS detection sensitivity. In addition, most small fragments were of maternal origin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The comparison between the CMA and NIPT-PLUS techniques shows that NIPT-PLUS has high sensitivity for detecting chromosomal aneuploidy and chromosomal copy number variations (CNVs) with fragments &gt;\u20095\u00a0M. However, the sensitivity of CNV for fragments &lt;\u20095\u00a0M is low, and the missed detection rate is high. Additionally, confined placental mosaicism and foetal mosaicism are the key factors causing false negatives in NIPT-PLUS, while maternal chromosomal abnormalities and confined placental mosaicism are key contributors to false positives, so appropriate genetic counselling is especially important for pregnant women before and after NIPT-PLUS testing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01285-2","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T03:25:15Z","timestamp":1693365915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion\/microduplication"],"prefix":"10.1186","volume":"28","author":[{"given":"Weifang","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"issue":"18","key":"1285_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT Mai","year":"2019","unstructured":"Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, et al. National population-based estimates for major birth defects, 2010\u20132014. Birth Defects Res. 2019;111(18):1420\u201335. https:\/\/doi.org\/10.1002\/bdr2.1589. (Epub 2019 Oct 3).","journal-title":"Birth Defects Res"},{"issue":"10","key":"1285_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.16288\/j.yczz.18-181","volume":"40","author":"LY Sun","year":"2018","unstructured":"Sun LY, Xing QH, He L. Retrospect and prospect of the genetic research on birth defects in China. Yi Chuan. 2018;40(10):800\u201313. https:\/\/doi.org\/10.16288\/j.yczz.18-181.","journal-title":"Yi Chuan"},{"issue":"1","key":"1285_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01213097","volume":"87","author":"J Nielsen","year":"1991","unstructured":"Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet. 1991;87(1):81\u20133. https:\/\/doi.org\/10.1007\/BF01213097.","journal-title":"Hum Genet"},{"issue":"5683","key":"1285_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.1098918","volume":"305","author":"B Lakshmi","year":"2004","unstructured":"Lakshmi B, Troge J, Alexander J, Young J, Lundin P, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305(5683):525\u20138. https:\/\/doi.org\/10.1126\/science.1098918.","journal-title":"Science"},{"issue":"5","key":"1285_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","volume":"86","author":"DT Miller","year":"2010","unstructured":"Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749\u201364. https:\/\/doi.org\/10.1016\/j.ajhg.2010.04.006.","journal-title":"Am J Hum Genet"},{"issue":"23","key":"1285_CR6","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","volume":"367","author":"RJ Wapner","year":"2012","unstructured":"Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1203382.","journal-title":"N Engl J Med"},{"issue":"6","key":"1285_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/01.gim.0000170992.63691.32","volume":"7","author":"SW Cheung","year":"2005","unstructured":"Cheung SW, Shaw CA, Yu W, Li Z, Ou Z, Patel A, et al. Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med. 2005;7(6):422\u201332. https:\/\/doi.org\/10.1097\/01.gim.0000170992.63691.32.","journal-title":"Genet Med"},{"issue":"4","key":"1285_CR8","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.4238\/2014.October.31.27","volume":"13","author":"HB Xu","year":"2014","unstructured":"Xu HB, Yang H, Liu G, Chen H. Systematic review of accuracy of prenatal diagnosis for abnormal chromosome diseases by microarray technology. Genet Mol Res. 2014;13(4):9115\u201321. https:\/\/doi.org\/10.4238\/2014.October.31.27.","journal-title":"Genet Mol Res"},{"issue":"3","key":"1285_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41436-019-0634-7","volume":"22","author":"H Wang","year":"2020","unstructured":"Wang H, Dong Z, Zhang R, Chau MHK, Yang ZJ, Tsang KYC, Wong HK, et al. Low-pass genome sequencing versus chromosomal microarray analysis: implementation in prenatal diagnosis. Genet Med. 2020;22(3):500\u201310. https:\/\/doi.org\/10.1038\/s41436-019-0634-7. (Epub 2019 Aug 26).","journal-title":"Genet Med"},{"issue":"3","key":"1285_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/pd.5212","volume":"38","author":"SB Hay","year":"2018","unstructured":"Hay SB, Sahoo T, Travis MK, Hovanes K, Dzidic N, Doherty C, et al. ACOG and SMFM guidelines for prenatal diagnosis: is karyotyping really sufficient? Prenat Diagn. 2018;38(3):184\u20139. https:\/\/doi.org\/10.1002\/pd.5212. (Epub 2018 Feb 6).","journal-title":"Prenat Diagn"},{"issue":"6","key":"1285_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jogc.2019.12.007","volume":"42","author":"X Xie","year":"2020","unstructured":"Xie X, Wang M, Goh ESY, Ungar WJ, Little J, Carroll JC, et al. Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions in average-risk pregnancies: a cost-effectiveness analysis. J Obstet Gynaecol Can. 2020;42(6):740-749.e12. https:\/\/doi.org\/10.1016\/j.jogc.2019.12.007. (Epub 2020 Jan 31).","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"1285_CR12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302\u201314. https:\/\/doi.org\/10.1002\/uog.17484. (Epub 2017 Jul 27).","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"19","key":"1285_CR13","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1056\/NEJMc1106975","volume":"365","author":"D Peters","year":"2011","unstructured":"Peters D, Chu TJ, Yatsenko SA, Hendrix N, Hogge WA, Surti U, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med. 2011;365(19):1847\u20138. https:\/\/doi.org\/10.1056\/NEJMc1106975.","journal-title":"N Engl J Med"},{"issue":"2","key":"1285_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fertnstert.2018.01.005","volume":"109","author":"B Levy","year":"2018","unstructured":"Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril. 2018;109(2):201\u201312. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.01.005.","journal-title":"Fertil Steril"},{"issue":"5","key":"1285_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30. (Epub 2015 Mar 5).","journal-title":"Genet Med"},{"issue":"11","key":"1285_CR16","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1038\/s41436-021-01150-9","volume":"23","author":"ER Riggs","year":"2021","unstructured":"Riggs ER, Andersen EF, Cherry EM, Kantarci S, Kearney H, Patel A, et al. Correction: Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2021;23(11):2230. https:\/\/doi.org\/10.1038\/s41436-021-01150-9.","journal-title":"Genet Med"},{"issue":"2","key":"1285_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/uog.15791","volume":"47","author":"AT Papageorghiou","year":"2016","unstructured":"Papageorghiou AT, Khalil A, Forman M, Hulme R, Mazey R, Mousa HA, et al. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13. Ultrasound Obstet Gynecol. 2016;47(2):188\u201393. https:\/\/doi.org\/10.1002\/uog.15791. (Epub 2015 Dec 28).","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"02","key":"1285_CR18","first-page":"146","volume":"42","author":"W Jie","year":"2021","unstructured":"Jie W, Xiaoping J, Liqiong W, et al. Analysis of influencing factors of fetal free DNA ratio in non-invasive prenatal screening. Int J Lab Med. 2021;42(02):146\u201350.","journal-title":"Int J Lab Med."},{"issue":"4","key":"1285_CR19","doi-asserted-by":"publisher","first-page":"562.e1","DOI":"10.1016\/j.ajog.2021.11.016","volume":"226","author":"I Maya","year":"2022","unstructured":"Maya I, SalzerSheelo L, Brabbing-Goldstein D, Matar R, Kahana S, Agmon-Fishman I, et al. Residual risk for clinically significant copy number variants in low-risk pregnancies, following exclusion of noninvasive prenatal screening-detectable findings. Am J Obstet Gynecol. 2022;226(4):562.e1-562.e8. https:\/\/doi.org\/10.1016\/j.ajog.2021.11.016.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1285_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jog.15115","volume":"48","author":"M Saito","year":"2022","unstructured":"Saito M, Tokunaka M, Goto M, Takita H, Arakaki T, Miyagami K, et al. The role of first-trimester ultrasound screening for women with positive noninvasive prenatal testing results. J Obstet Gynaecol Res. 2022;48(2):328\u201332. https:\/\/doi.org\/10.1111\/jog.15115.","journal-title":"J Obstet Gynaecol Res"},{"key":"1285_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62657","author":"Y Chen","year":"2022","unstructured":"Chen Y, Lu LKY, Zhang Y, Wang FF, Ni YH, Wang Q, et al. Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnancies. Am J Med Genet A. 2022. https:\/\/doi.org\/10.1002\/ajmg.a.62657.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1285_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12920-021-00955-6","volume":"14","author":"YS Ge","year":"2021","unstructured":"Ge YS, Li J, Zhuang JL, Zhang J, Huang YR, Tan MH, et al. Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 cases. BMC Med Genom. 2021;14(1):106. https:\/\/doi.org\/10.1186\/s12920-021-00955-6.","journal-title":"BMC Med Genom"},{"issue":"9","key":"1285_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41436-019-0467-4","volume":"21","author":"D Liang","year":"2019","unstructured":"Liang D, Cram DS, Tan H, Linpeng SY, Liu YD, Sun HY, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21(9):1998\u20132006. https:\/\/doi.org\/10.1038\/s41436-019-0467-4.","journal-title":"Genet Med"},{"issue":"4","key":"1285_CR24","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/genes12040478","volume":"12","author":"Y Lai","year":"2021","unstructured":"Lai Y, Zhu XF, He S, Dong ZR, Tang YQ, Xu FB, et al. Performance of cell-free DNA screening for fetal common aneuploidies and sex chromosomal abnormalities: a prospective study from a less developed autonomous region in Mainland China. Genes. 2021;12(4):478. https:\/\/doi.org\/10.3390\/genes12040478.","journal-title":"Genes"},{"issue":"4","key":"1285_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3760\/cma.j.cn511374-20200331-00221","volume":"38","author":"K Jin","year":"2021","unstructured":"Jin K, Luo JF, Zhang LP, Shen SS, Hu Y. Value of non-invasive prenatal testing for the detection of fetal chromosomal copy number variations. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021;38(4):329\u201334. https:\/\/doi.org\/10.3760\/cma.j.cn511374-20200331-00221.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"10","key":"1285_CR26","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/pd.6002","volume":"41","author":"P Shi","year":"2021","unstructured":"Shi P, Wang Y, Liang HB, Hou YQ, Chen D, Zhao GY, et al. The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes. Prenat Diagn. 2021;41(10):1332\u201342. https:\/\/doi.org\/10.1002\/pd.6002.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1285_CR27","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1038\/s41598-019-44018-4","volume":"9","author":"C Deng","year":"2019","unstructured":"Deng C, Zhu Q, Liu S, Liu JL, Bai T, Jing XS, et al. Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. Sci Rep. 2019;9(1):7767. https:\/\/doi.org\/10.1038\/s41598-019-44018-4.","journal-title":"Sci Rep"},{"issue":"6","key":"1285_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/pd.5049","volume":"37","author":"TS Hartwig","year":"2017","unstructured":"Hartwig TS, Ambye L, S\u00f8rensen S, J\u00f8rgensen FS. Discordant non-invasive prenatal testing (NIPT)\u2014a systematic review. Prenat Diagn. 2017;37(6):527\u201339. https:\/\/doi.org\/10.1002\/pd.5049.","journal-title":"Prenat Diagn"},{"issue":"2","key":"1285_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2353\/ajpath.2006.060161","volume":"169","author":"ML Tjoa","year":"2006","unstructured":"Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol. 2006;169(2):400\u20134. https:\/\/doi.org\/10.2353\/ajpath.2006.060161.","journal-title":"Am J Pathol"},{"issue":"2","key":"1285_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2353\/ajpath.2006.060161","volume":"172","author":"A Mardy","year":"2016","unstructured":"Mardy A, Wapner RJ. Confined placental mosaicism and its impact on confirmation of NIPT results. Am J Med Genet C Semin Med Genet. 2016;172(2):118\u201322. https:\/\/doi.org\/10.2353\/ajpath.2006.060161.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"1285_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/gim.2014.3","volume":"16","author":"FR Grati","year":"2014","unstructured":"Grati FR, Malvestiti F, Ferreira JCPB, Bajaj K, Gaetani E, Agrati C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med. 2014;16(8):620\u20134. https:\/\/doi.org\/10.1038\/gim.2014.3.","journal-title":"Genet Med"},{"issue":"8","key":"1285_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238245","volume":"15","author":"M Kucharik","year":"2020","unstructured":"Kucharik M, Gnip A, Hyblova M, Budis J, Strieskova L, Harsanyova M, et al. Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: detection limits of screened chromosomal microdeletions. PLoS ONE. 2020;15(8): e0238245. https:\/\/doi.org\/10.1371\/journal.pone.0238245.","journal-title":"PLoS ONE"},{"issue":"10","key":"1285_CR33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/pd.4640","volume":"35","author":"J Helgeson","year":"2015","unstructured":"Helgeson J, Wardrop J, Boomer T, Almasri E, Paxton WB, Saldivar JS, et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn. 2015;35(10):999\u20131004. https:\/\/doi.org\/10.1002\/pd.4640.","journal-title":"Prenat Diagn"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2020.10.050","volume":"256","author":"N Suzumori","year":"2021","unstructured":"Suzumori N, Sekizawa A, Takeda E, Samura O, Sasaki A, Akaishi R, et al. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13. Eur J Obstet Gynecol Reprod Biol. 2021;256:75\u201381. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.050.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"29","key":"1285_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020848","volume":"99","author":"X Li","year":"2020","unstructured":"Li X, Ju J, Shi YF, Li Y, Dong HW, Huang JH, et al. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with \u201cfalse negative\u201d result due to confined placental mosaicism: a case report. Medicine. 2020;99(29): e20848. https:\/\/doi.org\/10.1097\/MD.0000000000020848.","journal-title":"Medicine"},{"issue":"8","key":"1285_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1339","volume":"8","author":"Y Pei","year":"2020","unstructured":"Pei Y, Hu L, Liu JX, Wen LJ, Luo XJ, Lu J, et al. Efficiency of noninvasive prenatal testing for the detection of fetal microdeletions and microduplications in autosomal chromosomes. Mol Genet Genom Med. 2020;8(8): e1339. https:\/\/doi.org\/10.1002\/mgg3.1339.","journal-title":"Mol Genet Genom Med"},{"key":"1285_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.812781","volume":"10","author":"CC Deng","year":"2022","unstructured":"Deng CC, Liu SL. Factors affecting the fetal fraction in noninvasive prenatal screening: a review. Front Pediatr. 2022;10: 812781. https:\/\/doi.org\/10.3389\/fped.2022.812781.","journal-title":"Front Pediatr"},{"key":"1285_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13039-018-0397-x","volume":"11","author":"Y Tian","year":"2018","unstructured":"Tian Y, Zhang LL, Tian WF, Gao JS, Jia LT, Cui SH. Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform. Mol Cytogenet. 2018;11:49. https:\/\/doi.org\/10.1186\/s13039-018-0397-x.","journal-title":"Mol Cytogenet"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T23:44:33Z","timestamp":1700523873000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01285-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the declaration of Helsinki. This study was conducted with approval from the Ethics Committee of The Third Affiliated Hospital of Zhengzhou University. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors had no any personal, financial, commercial, or academic conflicts of interest separately.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}